Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 000774 ( Pmc/Corpus ); précédent : 0007739; suivant : 0007750 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Hydrolysis of Angiotensin Peptides by Human Angiotensin I–Converting Enzyme and the Resensitization of B
<sub>2</sub>
Kinin Receptors</title>
<author>
<name sortKey="Chen, Zhenlong" sort="Chen, Zhenlong" uniqKey="Chen Z" first="Zhenlong" last="Chen">Zhenlong Chen</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">16246972</idno>
<idno type="pmc">1564276</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564276</idno>
<idno type="RBID">PMC:1564276</idno>
<idno type="doi">10.1161/01.HYP.0000188905.20884.63</idno>
<date when="2005">2005</date>
<idno type="wicri:Area/Pmc/Corpus">000774</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000774</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Hydrolysis of Angiotensin Peptides by Human Angiotensin I–Converting Enzyme and the Resensitization of B
<sub>2</sub>
Kinin Receptors</title>
<author>
<name sortKey="Chen, Zhenlong" sort="Chen, Zhenlong" uniqKey="Chen Z" first="Zhenlong" last="Chen">Zhenlong Chen</name>
</author>
</analytic>
<series>
<title level="j">Hypertension</title>
<idno type="ISSN">0194-911X</idno>
<idno type="eISSN">1524-4563</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="P1">We measured the cleavage of angiotensin I (Ang I) metabolites by angiotensin I– converting enzyme (ACE) in cultured cells and examined how they augment actions of bradykinin B
<sub>2</sub>
receptor agonists. Monolayers of Chinese hamster ovary cells transfected to stably express human ACE and bradykinin B
<sub>2</sub>
receptors coupled to green fluorescent protein (B
<sub>2</sub>
GFP) or to express only coupled B
<sub>2</sub>
GFP receptors. We used 2 ACE-resistant bradykinin analogues to activate the B
<sub>2</sub>
receptors. We used high-performance liquid chromatography to analyze the peptides cleaved by ACE on cell monolayers and found that Ang 1-9 was hydrolyzed 18× slower than Ang I and ≈30% slower than Ang 1-7. Ang 1-7 was cleaved to Ang 1-5. Although μmol/L concentrations of slowly cleaved substrates Ang 1-7 and Ang 1-9 inhibit ACE, they resensitize the desensitized B
<sub>2</sub>
GFP receptors in nmol/L concentration, independent of ACE inhibition. This is reflected by release of arachidonic acid through a mechanism involving cross-talk between ACE and B
<sub>2</sub>
receptors. When ACE was not expressed, the Ang 1-9, Ang 1-7 peptides were inactive. Inhibitors of protein kinase C-α, phosphatases and Tyr-kinase blocked this resensitization activity, but not basal B
<sub>2</sub>
activation by bradykinin. Ang 1-9 and Ang 1-7 enhance bradykinin activity, probably by acting as endogenous allosteric modifiers of the ACE and B
<sub>2</sub>
receptor complex. Consequently, when ACE inhibitors block conversion of Ang I, other enzymes can still release Ang I metabolites to enhance the efficacy of ACE inhibitors.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7906255</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4217</journal-id>
<journal-id journal-id-type="nlm-ta">Hypertension</journal-id>
<journal-title>Hypertension</journal-title>
<issn pub-type="ppub">0194-911X</issn>
<issn pub-type="epub">1524-4563</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">16246972</article-id>
<article-id pub-id-type="pmc">1564276</article-id>
<article-id pub-id-type="doi">10.1161/01.HYP.0000188905.20884.63</article-id>
<article-id pub-id-type="manuscript">NIHMS6405</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Hydrolysis of Angiotensin Peptides by Human Angiotensin I–Converting Enzyme and the Resensitization of B
<sub>2</sub>
Kinin Receptors</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Zhenlong</given-names>
</name>
</contrib>
<aff id="A1">From the Department of Pharmacology, University of Illinois College of Medicine, Chicago.</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tan</surname>
<given-names>Fulong</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Erdös</surname>
<given-names>Ervin G.</given-names>
</name>
</contrib>
<aff id="A2">From the Departments of Pharmacology and Anesthesiology, University of Illinois College of Medicine, Chicago.</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Deddish</surname>
<given-names>Peter A.</given-names>
</name>
</contrib>
<aff id="A3">From the Departments of Pharmacology, Anatomy and Cell Biology, University of Illinois College of Medicine, Chicago.</aff>
</contrib-group>
<author-notes>
<corresp id="CR1">Correspondence to Ervin G. Erdös, MD, Professor, Department of Pharmacology, 835 S Wolcott (MC 868), Chicago, IL 60612. E-mail
<email>EGErdos@uic.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>9</month>
<year>2006</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>10</month>
<year>2005</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2005</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>13</day>
<month>9</month>
<year>2006</year>
</pub-date>
<volume>46</volume>
<issue>6</issue>
<fpage>1368</fpage>
<lpage>1373</lpage>
<abstract>
<p id="P1">We measured the cleavage of angiotensin I (Ang I) metabolites by angiotensin I– converting enzyme (ACE) in cultured cells and examined how they augment actions of bradykinin B
<sub>2</sub>
receptor agonists. Monolayers of Chinese hamster ovary cells transfected to stably express human ACE and bradykinin B
<sub>2</sub>
receptors coupled to green fluorescent protein (B
<sub>2</sub>
GFP) or to express only coupled B
<sub>2</sub>
GFP receptors. We used 2 ACE-resistant bradykinin analogues to activate the B
<sub>2</sub>
receptors. We used high-performance liquid chromatography to analyze the peptides cleaved by ACE on cell monolayers and found that Ang 1-9 was hydrolyzed 18× slower than Ang I and ≈30% slower than Ang 1-7. Ang 1-7 was cleaved to Ang 1-5. Although μmol/L concentrations of slowly cleaved substrates Ang 1-7 and Ang 1-9 inhibit ACE, they resensitize the desensitized B
<sub>2</sub>
GFP receptors in nmol/L concentration, independent of ACE inhibition. This is reflected by release of arachidonic acid through a mechanism involving cross-talk between ACE and B
<sub>2</sub>
receptors. When ACE was not expressed, the Ang 1-9, Ang 1-7 peptides were inactive. Inhibitors of protein kinase C-α, phosphatases and Tyr-kinase blocked this resensitization activity, but not basal B
<sub>2</sub>
activation by bradykinin. Ang 1-9 and Ang 1-7 enhance bradykinin activity, probably by acting as endogenous allosteric modifiers of the ACE and B
<sub>2</sub>
receptor complex. Consequently, when ACE inhibitors block conversion of Ang I, other enzymes can still release Ang I metabolites to enhance the efficacy of ACE inhibitors.</p>
</abstract>
<kwd-group>
<kwd>angiotensin</kwd>
<kwd>angiotensin-converting enzyme</kwd>
<kwd>bradykinin</kwd>
<kwd>enalapril</kwd>
<kwd>protein kinases</kwd>
</kwd-group>
<contract-num rid="HL1">R01 HL068580-04</contract-num>
<contract-num rid="HL1">R01 HL068580-03</contract-num>
<contract-num rid="HL1">R01 HL068580-02</contract-num>
<contract-num rid="HL1">R01 HL068580-01</contract-num>
<contract-num rid="HL1">R01 HL036473-20</contract-num>
<contract-num rid="HL1">R01 HL036473-19</contract-num>
<contract-num rid="HL1">R01 HL036473-18</contract-num>
<contract-num rid="HL1">R01 HL036473-17</contract-num>
<contract-sponsor id="HL1">National Heart, Lung, and Blood Institute : NHLBI</contract-sponsor>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000774  | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000774  | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021